1 / 18

Varian Medical Systems

Varian Medical Systems. By KJ Neish. History. Originally incorporated in 1948 as Varian Associates, Inc. Changed name to Varian Medical Systems, Inc. in April 1999 Fiscal Year-end Sept. 28, 2012 1Q results Jan. 23, 2013. The Company. Oncology Systems (78% 2012 revenues) X-ray (18%)

twyla
Télécharger la présentation

Varian Medical Systems

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Varian Medical Systems By KJ Neish

  2. History • Originally incorporated in 1948 as Varian Associates, Inc. • Changed name to Varian Medical Systems, Inc. in April 1999 • Fiscal Year-end Sept. 28, 2012 • 1Q results Jan. 23, 2013

  3. The Company • Oncology Systems (78% 2012 revenues) • X-ray (18%) • Other (4%)

  4. Oncology Systems segment • Provides medical devices and software for treating cancer • Linear accelerators • Brachytherapy afterloaders • Simulation and verification software • Hospitals, cancer care clinics, government institutions, research facilities, doctors’ offices

  5. Radiation Therapy • The use of focused energy to kill cancer cells • Used alone or in combination with surgery or chemotherapy • Different forms of treatment • The most common form involves delivering x-ray beams • 65% increase in new cases of cancer from 2008 to 2030

  6. X-ray Products segment • Design and manufacturer of x-ray components • X-ray tubes • Flat panel detectors • Toshiba Corp., Hitachi Medical Corp., GE healthcare • InfiMed acquisition • 20-25% market share

  7. Other • Ginzton Technology Center (GTC) • Security and Inspection (SIP) • Varian Particle Therapy (VPT)

  8. Growth • Emerging markets • Strategic global partnership with Siemens Medical Systems • Commercialization of proton therapy • Product innovation

  9. Emerging Markets • 2 linear accelerators/million. US has 13 • China • India • Regulatory clearance in India • Population over 1 bil. • 1 mil. new cases of cancer each year • Brazil • Competing for public tender of more than 80 units • Reverse auction bidding • Announced in Jan-Feb

  10. Strategic Partnership • Mutually market each other's products • Co-develop opportunities

  11. Proton Therapy • Latest innovation in the radiotherapy field • Proton particles • Less invasive, better targeting • Vital organs less at risk • 70% reduction in radiation exposure • Large-scale construction projects • Emory University and University of Maryland

  12. -National Association for Proton Therapy

  13. Product Innovation • EDGE • 510(k) clearance • Integrates technology with tools for real-time imaging and tracking • Launched in Nov • Lung, liver, and pancreatic cancer

  14. Comparable Analysis (0%)

  15. Discounted Cash Flow (100%) • Revenue • Smaller margins • SG&A increase as a % revenue • 4% intermediate growth rate • Cost of debt calculated based on last issuance • 9.35% undervalued

  16. Beta

  17. Questions

  18. BUY For Tall Firs and Svigals’ portfolio

More Related